Projekttitel
Developing First-In-Class INPP5A Inhibitors as the First Effective Therapy for All GNAQ/11 Mutated Metastatic Uveal Melanoma Patients
Projekttitel Englisch
Developing First-In-Class INPP5A Inhibitors as the First Effective Therapy for All GNAQ/11 Mutated Metastatic Uveal Melanoma Patients
